GLUE
Monte Rosa Therapeutics, Inc. · Healthcare
Versant Venture Capital Vi, L.P. sold $7.4M of Monte Rosa Therapeutics, Inc.
10% owner
Sold$7,395,203
$6.53Price
1,132,566Shares
−14%Stake
What GLUE did after the filing
- The stock from Tue, Sep 24 close, $5.69
- +64.5%
- S&P 500, same days
- +0.9%
Measured over 30 trading days, to the Nov 5 close.
Traded Fri, Sep 20. Filed Tue, Sep 24, 12:40 PM ET, during the session. Returns use the Sep 24 close and the Nov 5 close. Not investment advice.